1. Home
  2. BDTX vs EXFY Comparison

BDTX vs EXFY Comparison

Compare BDTX & EXFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDTX
  • EXFY
  • Stock Information
  • Founded
  • BDTX 2014
  • EXFY 2008
  • Country
  • BDTX United States
  • EXFY United States
  • Employees
  • BDTX N/A
  • EXFY N/A
  • Industry
  • BDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • EXFY Computer Software: Prepackaged Software
  • Sector
  • BDTX Health Care
  • EXFY Technology
  • Exchange
  • BDTX Nasdaq
  • EXFY Nasdaq
  • Market Cap
  • BDTX 181.4M
  • EXFY 165.4M
  • IPO Year
  • BDTX 2020
  • EXFY 2021
  • Fundamental
  • Price
  • BDTX $2.76
  • EXFY $1.80
  • Analyst Decision
  • BDTX Strong Buy
  • EXFY Strong Buy
  • Analyst Count
  • BDTX 5
  • EXFY 3
  • Target Price
  • BDTX $13.40
  • EXFY $4.75
  • AVG Volume (30 Days)
  • BDTX 914.3K
  • EXFY 729.6K
  • Earning Date
  • BDTX 08-07-2025
  • EXFY 08-07-2025
  • Dividend Yield
  • BDTX N/A
  • EXFY N/A
  • EPS Growth
  • BDTX N/A
  • EXFY N/A
  • EPS
  • BDTX 0.25
  • EXFY N/A
  • Revenue
  • BDTX $70,000,000.00
  • EXFY $144,251,000.00
  • Revenue This Year
  • BDTX N/A
  • EXFY $7.77
  • Revenue Next Year
  • BDTX N/A
  • EXFY $5.45
  • P/E Ratio
  • BDTX $11.03
  • EXFY N/A
  • Revenue Growth
  • BDTX N/A
  • EXFY 4.13
  • 52 Week Low
  • BDTX $1.20
  • EXFY $1.60
  • 52 Week High
  • BDTX $6.75
  • EXFY $4.13
  • Technical
  • Relative Strength Index (RSI)
  • BDTX 52.31
  • EXFY 35.99
  • Support Level
  • BDTX $2.22
  • EXFY $1.75
  • Resistance Level
  • BDTX $2.84
  • EXFY $1.92
  • Average True Range (ATR)
  • BDTX 0.20
  • EXFY 0.13
  • MACD
  • BDTX -0.01
  • EXFY -0.01
  • Stochastic Oscillator
  • BDTX 72.00
  • EXFY 30.77

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

About EXFY Expensify Inc.

Expensify Inc is a cloud-based expense management software platform that helps various businesses simplify the way to manage money. It is used to scan and reimburse receipts from flights, hotels, coffee shops, office supplies and ride shares. People use Expensify's free features, which include corporate cards, expense tracking, next-day reimbursement, invoicing, bill pay and travel booking in one app.

Share on Social Networks: